Alnylam Pharmaceuticals reported $588.2M in Equity Capital and Reserves for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Agios Pharmaceuticals AGIO:US $ 1291.97M 102.79M
Arrowhead Research ARWR:US $ 452.27M 79.71M
Avrobio Inc AVRO:US $ 143.16M 26.31M
Bluebird Bio BLUE:US $ 374.28M 496.25M
IONIS PHARMACEUT IONS:US $ 772M 241.46M
Mirati Therapeutics MRTX:US $ 1249.28M 147.76M
Regulus Therapeutics RGLS:US $ 49.24M 5.72M
Sangamo Biosciences SGMO:US $ 334.52M 40.82M
Xencor XNCR:US $ 763.02M 29.52M